Eribulin in Angiosarcoma and Epithelioid Hemangioendothelioma (EHE)

Conditions:   Angiosarcoma;   Epithelioid Hemangioendothelioma Intervention:   Drug: Eribulin Sponsors:   Massachusetts General Hospital;   Eisai Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials